Healthcare · Vaccine antigens production

Vaccine antigens production in Indonesia in 2026

Despite being the world's fourth most populous country, Indonesia produced zero vaccine antigens (0 million doses) in 2026, ranking 72 out of 197. This is paradoxical: the country has a strong pharmaceutical base (Bio Farma is one of the world's largest vaccine producers by dose volume), but it focuses on fill-and-finish rather than antigen synthesis. The lack of domestic antigen production makes Indonesia reliant on imports from China and India, a vulnerability starkly exposed during the COVID-19 pandemic.

Data for 2026 · unit: million doses
Position

Indonesia world ranking

#72 / 197

Country position on the scale from last to first place for this indicator.

ID
#72
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
2
1990
5
2000
5
2010
10
2020
0
2025
0
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Indonesia — how much?
Based on 2026 data — 0 million doses. This is rank #72 out of 197 countries.
What is Indonesia's rank by Vaccine antigens production?
Indonesia ranks #72 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Indonesia?
Over the available period the indicator changed from 1 to 0 million doses.